$OBIO 8-K SEC Filings

Filed On	Filing
01 Oct 2026	8-K: Regulation FD Disclosure; Other Events 330 patients randomized as of September 30, 2026, surpassing full trial enrollment target
08 Sep 2026	8-K: Regulation FD Disclosure Accelerating high - impact technologies to patients through risk - reward sharing partnerships Corporate Overview \| September 2026 Nasdaq : OBIO
23 Jun 2026	8-K: Submission of Matters to a Vote of Security Holders
13 Feb 2026	8-K: Departure/Election of Directors or Officers; Compensation
12 Jan 2026	8-K: Other Events
13 Nov 2025	8-K: Regulation FD Disclosure
30 Oct 2025	8-K: Regulation FD Disclosure
28 Oct 2025	8-K: Entry into a Material Definitive Agreement; Termination of a Material Definitive Agreement +3 more
04 Aug 2025	8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure +1 more
31 Jul 2025	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +3 more
24 Jun 2025	8-K: Submission of Matters to a Vote of Security Holders
29 Apr 2025	8-K: Regulation FD Disclosure; Other Events
03 Mar 2025	8-K: Regulation FD Disclosure
25 Feb 2025	8-K: Departure/Election of Directors or Officers; Compensation
05 Feb 2025	8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
12 Aug 2024	8-K: Other Events
30 Jul 2024	8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
20 Jun 2024	8-K: Submission of Matters to a Vote of Security Holders
11 Jun 2024	8-K: Regulation FD Disclosure
29 Mar 2024	8-K: Other Events

Comments